Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001294404 | SCV001483282 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2023-11-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035607 | SCV004928469 | uncertain significance | Inborn genetic diseases | 2024-02-28 | criteria provided, single submitter | clinical testing | The c.1301G>A (p.G434D) alteration is located in exon 10 (coding exon 9) of the COL12A1 gene. This alteration results from a G to A substitution at nucleotide position 1301, causing the glycine (G) at amino acid position 434 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |